PRA ProAssurance: Enterprise Value to Sales Volume

Public company logo of ProAssurance (PRA)

ProAssurance Corporation (PRA) products for medical professionals have reached maturity, remaining critical amid rising judicial payouts. The business's EV-to-revenue multiple reflects current dynamics, with the parameter stabilizing at 0.00. Social inflation and portfolio volatility limit the company's resilience. High barriers to entry in this niche curb competition, despite the risk of price dumping by insurance behemoths.

ProAssurance - PRA Enterprise Value-to-Revenue Ratio (period 11/23/2025 - 07/11/2026)

PRA (ProAssurance Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Initial company analysis:PRA (ProAssurance)
Mass-produced product of ProAssurance Group

ProAssurance Corporation (PRA) is integrating the environmental sustainability of clinics into its insurance portfolios, optimizing risks through digitalization. The EV/Sales metric assesses the total enterprise value relative to revenue, excluding the impact of debt load. Low values of this indicator may signal that the company's assets are undervalued. This analysis allows for the determination of the efficiency of medical service monetization without considering leverage. The historical trend of the EV/Sales metric confirms the fundamental stability of the business.